Paper30972754
Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery.
Leonard A and 8 others. Br J Haematol, 2019. Cited by 64 papers, by iCite.
Cite this record
ConductScience Library. Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery. Papers, record 30972754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30972754
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anemia, Sickle Cell | Major topic |
| Antigens, CD34 | Major topic |
| Erythropoiesis | Major topic |
| Hematopoietic Stem Cells | Major topic |
| Stress, Physiological | Major topic |
| Adult | |
| Female | |
| Flow Cytometry | |
| Humans | |
| Inflammation | |
| Male |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| ZIA HL006007 | Intramural NIH HHS | United States | ZIAHL006007 | PubMed | NIH RePORTER |
| ZIA HL006009 | Intramural NIH HHS | United States | ZIAHL006009 | PubMed | NIH RePORTER |
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29419425 | Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results. | Haematologica | 2018 | https://conductscience.org/library/papers/29419425 | PubMed |
| 2 | 27820943 | CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. | Nature | 2016 | https://conductscience.org/library/papers/27820943 | PubMed |
| 3 | 27510901 | Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy. | Sci Transl Med | 2016 | https://conductscience.org/library/papers/27510901 | PubMed |
| 4 | 12480697 | SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. | Blood | 2003 | https://conductscience.org/library/papers/12480697 | PubMed |
| 5 | 26758915 | Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. | Blood | 2016 | https://conductscience.org/library/papers/26758915 | PubMed |
| 6 | 19995398 | Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises. | Br J Haematol | 2010 | https://conductscience.org/library/papers/19995398 | PubMed |
| 7 | 8595612 | Effect of heparin anticoagulation on neutrophil adhesion molecules and release of IL8: C3 is not essential. | Cardiovasc Res | 1995 | https://conductscience.org/library/papers/8595612 | PubMed |
| 8 | 22264835 | Monocytes from sickle cell disease patients induce differential pulmonary endothelial gene expression via activation of NF-κB signaling pathway. | Mol Immunol | 2012 | https://conductscience.org/library/papers/22264835 | PubMed |
| 9 | 22901265 | Hematopoietic stem cell expansion: challenges and opportunities. | Ann N Y Acad Sci | 2012 | https://conductscience.org/library/papers/22901265 | PubMed |
| 10 | 29472357 | Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion. | Haematologica | 2018 | https://conductscience.org/library/papers/29472357 | PubMed |
| 11 | 9808852 | Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis. | J Vasc Surg | 1998 | https://conductscience.org/library/papers/9808852 | PubMed |
| 12 | 26064103 | Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review. | Adv Pharmacol Sci | 2015 | https://conductscience.org/library/papers/26064103 | PubMed |
| 13 | 19004988 | Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. | J Leukoc Biol | 2009 | https://conductscience.org/library/papers/19004988 | PubMed |
| 14 | 11122087 | Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. | Br J Haematol | 2000 | https://conductscience.org/library/papers/11122087 | PubMed |
| 15 | 11985552 | Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease. | Clin Lab Haematol | 2002 | https://conductscience.org/library/papers/11985552 | PubMed |
| 16 | 15145217 | Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells. | Exp Hematol | 2004 | https://conductscience.org/library/papers/15145217 | PubMed |
| 17 | 9808586 | Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes. | Blood | 1998 | https://conductscience.org/library/papers/9808586 | PubMed |
| 18 | 27601644 | Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27601644 | PubMed |
| 19 | 9254660 | Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. | J Exp Med | 1997 | https://conductscience.org/library/papers/9254660 | PubMed |
| 20 | 28330619 | Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy. | Stem Cell Reports | 2017 | https://conductscience.org/library/papers/28330619 | PubMed |
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42219144 | Adaptive Immune Remodeling in Sickle Cell Disease: Linking Hemolysis-Driven Inflammation to Immune Dysfunction. | Exp Hematol | 2026 | https://conductscience.org/library/papers/42219144 | PubMed |
| 42052798 | Circulating erythropoietin concentration associates with thromboembolism in sickle cell disease. | Br J Haematol | 2026 | https://conductscience.org/library/papers/42052798 | PubMed |
| 42008008 | Clinical outcomes of lentiviral vector gene therapy for sickle cell disease. | Blood Adv | 2026 | https://conductscience.org/library/papers/42008008 | PubMed |
| 41991612 | Intravenous administration of ex vivo expanded human umbilical cord blood-derived CD34⁺ cells in a preterm hypoxic-ischemic encephalopathy mouse model. | Sci Rep | 2026 | https://conductscience.org/library/papers/41991612 | PubMed |
| 41905703 | Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy. | Transplant Cell Ther | 2026 | https://conductscience.org/library/papers/41905703 | PubMed |
| 41830512 | Exploring Affordable Curative Therapy for Sickle Cell Disease in Africa: A Comprehensive Overview. | Am J Hematol | 2026 | https://conductscience.org/library/papers/41830512 | PubMed |
| 41741059 | Emerging Considerations in Transfusion Medicine: Hematopoietic Stem and Progenitor Cell Collection for Gene Therapy for Sickle Cell Disease and Transfusion-Dependent Thalassemia. | Clin Lab Med | 2026 | https://conductscience.org/library/papers/41741059 | PubMed |
| 41282081 | IFN-I-Mediated Transcriptional Reprogramming Drives Myeloid-skewed Hematopoiesis in Sickle Cell Anemia. | Res Sq | 2025 | https://conductscience.org/library/papers/41282081 | PubMed |
| 41253147 | Gene therapy for hemoglobinopathies: Clinical trial results and biology of hematopoietic stem cell and the bone marrow niche. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/41253147 | PubMed |
| 40966451 | Hematopoietic stem cell therapy with gene modification to treat sickle cell disease. | Stem Cells Transl Med | 2025 | https://conductscience.org/library/papers/40966451 | PubMed |
| 40472294 | To pursue gene therapy or not? Is it feasible after graft failure in allogeneic hematopoietic cell transplant recipients. | Blood Adv | 2025 | https://conductscience.org/library/papers/40472294 | PubMed |
| 39633531 | Reduced GATA1 levels are associated with ineffective erythropoiesis in sickle cell anemia. | Haematologica | 2025 | https://conductscience.org/library/papers/39633531 | PubMed |
| 39568202 | From old to new: Repurposed drugs in the battle towards curing sickle cell disease. | Br J Haematol | 2025 | https://conductscience.org/library/papers/39568202 | PubMed |
| 39356871 | How I treat sickle cell disease with gene therapy. | Blood | 2024 | https://conductscience.org/library/papers/39356871 | PubMed |
| 39044427 | Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses. | Mol Ther | 2024 | https://conductscience.org/library/papers/39044427 | PubMed |
| 38941538 | Immune modulation permits tolerance and engraftment in a murine model of late-gestation transplantation. | Blood Adv | 2024 | https://conductscience.org/library/papers/38941538 | PubMed |
| 38506770 | Ex vivo culture resting time impacts transplantation outcomes of genome-edited human hematopoietic stem and progenitor cells in xenograft mouse models. | Cytotherapy | 2024 | https://conductscience.org/library/papers/38506770 | PubMed |
| 38396832 | Reticulocyte Antioxidant Enzymes mRNA Levels versus Reticulocyte Maturity Indices in Hereditary Spherocytosis, β-Thalassemia and Sickle Cell Disease. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38396832 | PubMed |
| 38262104 | Effect of voxelotor on murine bone marrow and peripheral blood with hematopoietic progenitor cell mobilization for gene therapy of sickle cell disease. | Blood Cells Mol Dis | 2024 | https://conductscience.org/library/papers/38262104 | PubMed |
| 38027257 | Genome editing for sickle cell disease: still time to correct? | Front Pediatr | 2023 | https://conductscience.org/library/papers/38027257 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30972754
GET https://conductscience.org/api/papers/v1/30972754/references?page=2